Document
IPR2022-00142, No. 2016 Exhibit - DrugsFDA Alphagan 05% (P.T.A.B. Feb. 22, 2022)
Cite Document
IPR2022-00142, No. 2016 Exhibit - DrugsFDA Alphagan 05% (P.T.A.B. Feb. 22, 2022)
+ More Snippets
Document
IPR2022-00142, No. 2014 Exhibit - Alphagan P 015% 01% Label 2006 (P.T.A.B. Feb. 22, 2022)
Cite Document
IPR2022-00142, No. 2014 Exhibit - Alphagan P 015% 01% Label 2006 (P.T.A.B. Feb. 22, 2022)
+ More Snippets
Document
IPR2022-00142, No. 1056 Exhibit - Conrad, et al (P.T.A.B. Dec. 16, 2022)
Cite Document
IPR2022-00142, No. 1056 Exhibit - Conrad, et al (P.T.A.B. Dec. 16, 2022)
+ More Snippets
Document
IPR2022-00142, No. 1102 Exhibit - Aslanides IM, et al 2005 (P.T.A.B. Dec. 16, 2022)
Cite Document
IPR2022-00142, No. 1102 Exhibit - Aslanides IM, et al 2005 (P.T.A.B. Dec. 16, 2022)
+ More Snippets
Document
IPR2022-00142, No. 1072 Exhibit - Bausch Fourth Quarter 2020 Earnings Call Transcript, dated February 24, 2021 Part 1 of 2 (P.T.A.B. Dec. 16, 2022)
Cite Document
IPR2022-00142, No. 1072 Exhibit - Bausch Fourth Quarter 2020 Earnings Call Transcript, dated February 24, 2021 Part 1 of 2 (P.T.A.B. Dec. 16, 2022)
+ More Snippets
Document
IPR2022-00142, No. 1091 Exhibit - Duka, et al (P.T.A.B. Dec. 16, 2022)
Cite Document
IPR2022-00142, No. 1091 Exhibit - Duka, et al (P.T.A.B. Dec. 16, 2022)
+ More Snippets
Document
IPR2022-00142, No. 1060 Exhibit - Brimonidine Tartrate, DrugsFDA FDA Approved Drugs (P.T.A.B. Dec. 16, 2022)
Cite Document
IPR2022-00142, No. 1060 Exhibit - Brimonidine Tartrate, DrugsFDA FDA Approved Drugs (P.T.A.B. Dec. 16, 2022)
+ More Snippets
Document
IPR2022-00142, No. 1070-2 Exhibit - Bausch Fourth Quarter 2018 Earnings Call Transcript, dated February 20, 2019 Part 2 of 2 (P.T.A.B. Dec. 16, 2022)
Cite Document
IPR2022-00142, No. 1070-2 Exhibit - Bausch Fourth Quarter 2018 Earnings Call Transcript, dated February 20, 2019 Part 2 of 2 (P.T.A.B. Dec. 16, 2022)
+ More Snippets
Document
IPR2022-00142, No. 1059 Exhibit - Srinivasan, S and Venkiteshwar, M (P.T.A.B. Dec. 16, 2022)
Cite Document
IPR2022-00142, No. 1059 Exhibit - Srinivasan, S and Venkiteshwar, M (P.T.A.B. Dec. 16, 2022)
+ More Snippets
Document
IPR2022-00142, No. 1078 Exhibit - 2019 Rose Gold Winner, Lumify® Redness Reliever Drops (P.T.A.B. Dec. 16, 2022)
Cite Document
IPR2022-00142, No. 1078 Exhibit - 2019 Rose Gold Winner, Lumify® Redness Reliever Drops (P.T.A.B. Dec. 16, 2022)
+ More Snippets
Document
IPR2022-00142, No. 2032 Exhibit - 67 Fed Reg 3,060 (P.T.A.B. Aug. 29, 2022)
Cite Document
IPR2022-00142, No. 2032 Exhibit - 67 Fed Reg 3,060 (P.T.A.B. Aug. 29, 2022)
+ More Snippets
Document
IPR2022-00142, No. 2038 Exhibit - Alphagan P 015% Chemistry Review (P.T.A.B. Aug. 29, 2022)
Cite Document
IPR2022-00142, No. 2038 Exhibit - Alphagan P 015% Chemistry Review (P.T.A.B. Aug. 29, 2022)
+ More Snippets
Document
IPR2022-00142, No. 2176 Exhibit - Raviola 1983 (P.T.A.B. Aug. 29, 2022)
Cite Document
IPR2022-00142, No. 2176 Exhibit - Raviola 1983 (P.T.A.B. Aug. 29, 2022)
+ More Snippets
Document
IPR2022-00142, No. 2069 Exhibit - Bausch Jan 2022 S 1, Part 1 of 3 (P.T.A.B. Aug. 29, 2022)
Cite Document
IPR2022-00142, No. 2069 Exhibit - Bausch Jan 2022 S 1, Part 1 of 3 (P.T.A.B. Aug. 29, 2022)
+ More Snippets
Document
IPR2022-00142, No. 1088 Exhibit - Wilson, et al (P.T.A.B. Dec. 16, 2022)
Cite Document
IPR2022-00142, No. 1088 Exhibit - Wilson, et al (P.T.A.B. Dec. 16, 2022)
+ More Snippets